|
AMZ2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.438500E-04 |
| Normal-vs-Stage3 |
3.8772999999992E-05 |
| Normal-vs-Stage4 |
1.489990E-02 |
| Stage1-vs-Stage2 |
5.014400E-01 |
| Stage1-vs-Stage3 |
8.193000E-01 |
| Stage1-vs-Stage4 |
1.603240E-01 |
| Stage2-vs-Stage3 |
7.432400E-01 |
| Stage2-vs-Stage4 |
2.467800E-01 |
| Stage3-vs-Stage4 |
1.894190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.08989997214127E-09 |
| Normal-vs-Asian |
5.606100E-02 |
| Caucasian-vs-AfricanAmerican |
1.448380E-02 |
| Caucasian-vs-Asian |
8.243400E-01 |
| AfricanAmerican-vs-Asian |
2.540800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.4432899320127E-15 |
| Male-vs-Female |
1.441080E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.45020000000373E-06 |
| Normal-vs-Extreme_Weight |
1.69853020537403E-12 |
| Normal-vs-Obese |
7.069900220813E-11 |
| Normal-vs-Extreme_Obese |
6.078500E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.757800E-01 |
| Normal_Weight-vs-Obese |
5.201800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.959800E-01 |
| Extreme_Weight-vs-Obese |
5.200600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.860400E-01 |
| Obese-vs-Extreme_Obese |
7.612200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.38429999999124E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.100440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.049600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.875900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.662710E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.118350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.395700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.902500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.2804999999515E-07 |
| Normal-VS-KIRP CIMP |
9.390900E-04 |
| Normal-VS-Unclassified PRCC |
1.88519999999581E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.845600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.080400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.866000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.262400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.810400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.472960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.16960000468214E-08 |
| Normal-vs-N1 |
4.771800E-04 |
| Normal-vs-N2 |
1.134390E-01 |
| N0-vs-N1 |
1.809750E-01 |
| N0-vs-N2 |
7.417700E-02 |
| N1-vs-N2 |
6.085200E-01 |
|
|
